- Price
- $42.33
- Day
- 0.00%
- Mkt Cap
- $8.73B
- 52W Range
- $32.53 – $57.82
- Volume
- 2.29M
- Beta
- 0.62
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
Allspring Global Investments Holdings LLC lessened its holdings in shares of Qiagen N.V. (NYSE: QGEN) by 21.6% during the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 2,481,645 shares of the company's stock after selling 683,160 shares during the period. Allspring Global Investments Holdings LLC owned 1.20%
Read full article
GERMANTOWN, Md., & VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today highlighted its portfolio of molecular testing solutions supporting the public health response to the growing number of cyclosporiasis cases reported across the United States. More than 1,600 U.S. cases of cyclosporiasis have been confirmed since May, along with another 7,000 potential cases, as health authorities investigate multiple outbreaks involving Cyclospora cayetanensis,.
Read full article
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the second quarter of 2026. Press release date / time: Wednesday, August 5 shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Thursday, August 6, at 15:30 Frankfurt time / 14:30 London time / 09:30 New York time. Three options for joining the conference call Register for call back connection - Click her.
Read full article